REPROGRAM-01, a phase II study of regorafenib in combination with a multimodal metronomic chemotherapy in patients with metastatic colorectal cancer

被引：0
|
作者：
Klajer, E. [1 ]
Jary, M. [1 ,2 ]
Borg, C. [1 ,2 ]
Kim, S. [1 ,2 ,3 ]
Vernerey, D. [2 ,3 ]
Henriques, J. [3 ]
N'Guyen, T. [1 ]
Nasri, M. [1 ]
Almotlak, H. [1 ]
Babre, J. [1 ]
Meurisse, A.
Fratte, S. [4 ]
Fein, F. [5 ]
Calcagno, F. [1 ]
Chanut, L.
Spehner, L. [2 ]
Rebucci-Peixoto, M. [6 ]
Vienot, A. [1 ,2 ]
机构：
[1] Univ Hosp Besancon, Dept Med Oncol, Besancon, France
[2] Univ Bourgogne Franche Comte, Interact Hote Greffon Tumeur Ingn Cellulaire & Ge, INSERM, EFS BFC,UMR1098,RIGHT, Besancon, France
[3] Univ Hosp Besancon, Methodol & Qual Life Oncol Unit, Besancon, France
[4] Nord Franche Comte Hosp, Dept Med Oncol, Besancon, France
[5] Univ Hosp Besancon, Dept Gastroenterol, Besancon, France
[6] Univ Hosp Besancon, Ctr Invest Clin, CIC 1431, Besancon, France
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
509TiP
引用
收藏
页码：S581 / S581
页数：1
相关论文
共 50 条
  • [41] A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients
    G Allegrini
    A Falcone
    A Fioravanti
    M T Barletta
    P Orlandi
    F Loupakis
    E Cerri
    G Masi
    A Di Paolo
    R S Kerbel
    R Danesi
    M Del Tacca
    G Bocci
    British Journal of Cancer, 2008, 98 : 1312 - 1319
  • [42] A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients
    Allegrini, G.
    Falcone, A.
    Fioravanti, A.
    Barletta, M. T.
    Orlandi, P.
    Loupakis, F.
    Cerri, E.
    Masi, G.
    Di Paolo, A.
    Kerbel, R. S.
    Danesi, R.
    Del Tacca, M.
    Bocci, G.
    BRITISH JOURNAL OF CANCER, 2008, 98 (08) : 1312 - 1319
  • [43] A phase II study of capecitabine and weekly docetaxel combination chemotherapy in patients with metastatic breast cancer.
    Puglisi, F
    Scalone, S
    Minisini, AM
    Mansutti, M
    Crivellari, D
    Buonadonna, A
    Zanetti, M
    Ermacora, P
    Piga, A
    Veronesi, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 78S - 78S
  • [44] Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: phase II study.
    Tanaka, M.
    Tamura, K.
    Anan, K.
    Ohno, S.
    Nishimura, R.
    Yamamoto, Y.
    Masuda, N.
    Mitsuyama, S.
    CANCER RESEARCH, 2009, 69 (02) : 383S - 384S
  • [45] Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancer
    Kim, K
    Nam, E
    Lee, NS
    Lee, HR
    Lee, JY
    Lee, HR
    Park, SH
    Oh, SY
    Kim, JH
    Song, SY
    Park, JO
    Kim, WS
    Jung, CW
    Im, YH
    Lee, MH
    Lee, WY
    Chun, H
    Park, CH
    Park, K
    Kang, WK
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (04): : 354 - 357
  • [46] SILYBIN IN COMBINATION WITH REGORAFENIB AS A NOVEL POTENTIAL STRATEGY FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER PATIENTS
    Dallio, M.
    Troiani, T.
    Di Sarno, R.
    Belli, V.
    Napolitano, S.
    Gravina, A. G.
    Sgambato, D.
    Romano, M.
    Ciardiello, F.
    Loguercio, C.
    Federico, A.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 : E181 - E182
  • [47] Metronomic irinotecan and standard FOLFIRI regimen as first-line chemotherapy in metastatic colorectal cancer (MCRC). Final results of phase II study
    Nardi, M.
    Azzarello, D.
    Del Medico, P.
    Giannicola, R.
    Falzea, A.
    Giuffre, C.
    Maisano, R.
    Panuccio, V.
    Raffaele, M.
    Zavettieri, M.
    Avallone, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)
    Jeffrey Melson Clarke
    Gerard C. Blobe
    John H. Strickler
    Hope Elizabeth Uronis
    S. Yousuf Zafar
    Michael Morse
    Evan Dropkin
    Leigh Howard
    Margot O’Neill
    Christel N. Rushing
    Donna Niedzwiecki
    Hollie Watson
    Emily Bolch
    Christy Arrowood
    Yingmiao Liu
    Andrew B. Nixon
    Herbert I. Hurwitz
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 909 - 917
  • [49] A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial)
    Clarke, Jeffrey Melson
    Blobe, Gerard C.
    Strickler, John H.
    Uronis, Hope Elizabeth
    Zafar, S. Yousuf
    Morse, Michael
    Dropkin, Evan
    Howard, Leigh
    O'Neill, Margot
    Rushing, Christel N.
    Niedzwiecki, Donna
    Watson, Hollie
    Bolch, Emily
    Arrowood, Christy
    Liu, Yingmiao
    Nixon, Andrew B.
    Hurwitz, Herbert I.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (04) : 909 - 917
  • [50] Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis
    Hong, Junshik
    Han, Sae-Won
    Ham, Hye Seon
    Kim, Tae-Yong
    Choi, In Sil
    Kim, Byung-Su
    Oh, Do-Youn
    Im, Seock-Ah
    Kang, Gyeong Hoon
    Bang, Yung-Jue
    Kim, Tae-You
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1323 - 1331
12345